OCUL: Ocular Therapeutix, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,010.59
Enterprise Value ($M) 686.99
Book Value ($M) 315.34
Book Value / Share 1.98
Price / Book 3.20
NCAV ($M) 298.40
NCAV / Share 1.88
Price / NCAV 3.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.49
Return on Assets (ROA) -0.36
Return on Equity (ROE) -0.47

Liquidity (mrq)
Quick Ratio 10.59
Current Ratio 10.66

Balance Sheet (mrq) ($M)
Current Assets 440.99
Assets 457.94
Liabilities 142.59
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 63.72
Operating Income -173.38
Net Income -193.51
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -134.68
Cash from Investing -1.29
Cash from Financing 332.11

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G/A Opaleye Management Inc. 2.76 -28.46
11-14 13G Avoro Capital Advisors LLC 7.90
11-14 13G/A Venrock Healthcare Capital Partners III, L.P. 8.70 76.96
11-12 13G/A Vanguard Group Inc 5.37 0.00
11-08 13G/A BlackRock, Inc. 7.30 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-03 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-07 419,322 1,910,485 21.95
2025-04-04 1,032,279 2,661,530 38.79
2025-04-03 714,892 1,654,574 43.21
2025-04-02 569,855 1,701,627 33.49

(click for more detail)

Similar Companies
NRIX – Nurix Therapeutics, Inc. NTLA – Intellia Therapeutics, Inc.
OCS – Oculis Holding AG OKUR – OnKure Therapeutics, Inc.
OMER – Omeros Corporation


Financial data and stock pages provided by
Fintel.io

Finpedia: Ocular Therapeutix